ADRIBLASTINA-RD 50mg Injection 1s

 2,394.39

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 50mg
Drug Form : Injection
Pack Size : 1s
Does this requires a prescription ?Yes

Doxorubicin (HCl):50mg | Cytotoxic (anti-neoplastic) drugs

Alternate brands

  • RUBICIN 50mg Injection 25ml
     2,090.00
  • You can save 304.39
  • KU DOXORUBICIN 50mg Injection Vial
     1,782.00
  • You can save 612.39
  • DELDOXIN 50mg Injection 25ml
     1,716.00
  • You can save 678.39
  • DOXOBIN 50mg Injection 1s
     1,800.00
  • You can save 594.39
  • DOXOCIN 50mg Injection Vial
     1,000.00
  • You can save 1394.39

    Manufactured / Marketed By : Pfizer

    Product Form : Injection

    Pack Size : 1s

    Ingredients : Doxorubicin (HCl):50mg

    Generic Category : Cytotoxic (anti-neoplastic) drugs

    Reviews

    There are no reviews yet.

    Be the first to review “ADRIBLASTINA-RD 50mg Injection 1s”

    How it works

    ADRIBLASTINA-RD 50mg Injection 1s is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

    Side effects

    Major & minor side effects for ADRIBLASTINA-RD 50mg Injection 1s

    • Decrease in white blood cells and platelets severe
    • Pain at the injection site severe
    • Fever with chills severe
    • Skin rash severe
    • Hair loss
    • Nausea and Vomiting
    • Mouth ulcers
    • Loss of appetite
    • Diarrhea
    • Weight loss

    Uses of ADRIBLASTINA-RD 50mg Injection 1s

    What is it prescribed for?

    • Ovarian Cancer

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is used in the treatment of the cancer that affects the female reproductive system.

    • Breast Cancer

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is used in the treatment of breast cancer.

    • Hodgkin's Disease

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is used in the treatment of cancer that affects the immune system.

    • Multiple Myeloma

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is used in the treatment of cancer that affects the plasma cells (a type of blood cell) inside the bone marrow.

    Concerns

    Frequently asked questions

    • Onset of action

      The peak levels of this medicine can be reached immediately after intravenous injection.

    • Duration of Effect

      The effect of this medicine lasts for an average duration of 1 to 2 days

    • Safe with Alchohol?

      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

    • Is it habit forming?

      No habit forming tendency has been reported.

    • Usage in pregnancy?

      This medicine is not recommended for use in pregnant women.

    • Usage while breast-feeding?

      This medicine is not recommended for use in breastfeeding women.

    When not to use?

    • Allergy

      Not recommended in patients with known history of allergy to ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection.

    Warnings

    Warnings for special population
    • Pregnancy

      This medicine is not recommended for use in pregnant women.

    • Breast-feeding

      This medicine is not recommended for use in breastfeeding women.

    General Warnings
    • Effect on heart

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection may increase the risk of toxic effects on the heart and could lead to acute left ventricular failure. Patients with history of heart disease need close monitoring while receiving this medicine.

    • Infections

      The chances of infections occurring are more in patients receiving this medicine. Hold the chemotherapy and start with broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary in such cases.

    • Blood cell count

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is known to lower the white blood cell count (neutrophils) in patients with risk factors such as pre-existing diseases or medicines. Close monitoring of blood cell count is necessary. Do not start the treatment if the blood cell count is low.

    • Secondary oral neoplasms

      ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection is known to increase the risk of secondary cancers, most frequently in the mouth. Close monitoring of symptoms like mouth ulcers, bleeding is necessary. The treatment should be discontinued if secondary cancer develops.

    Dosage

    • Missed Dose

      It is advised that you do not miss any dose. If you miss any dose, you should contact your doctor immediately.

    • Overdose

      Seek emergency medical treatment or contact the doctor in case of an overdose.

    Interactions

    Interaction with Medicines
    • Clozapine severe
    • Diltiazem moderate
    • Live attenuated vaccines and related products severe
    • Dexamethasone moderate

    General Instructions

    Take ADRIBLASTINA-RD 50mg Injection 1s 50 mg Injection under the supervision of a qualified healthcare professional. It should be given with other chemotherapy agents in multiple cycles. It is important to receive every scheduled dose for better cancer suppression. The blood cell counts should be monitored before initiating the treatment. Close monitoring of heart function is necessary while receiving this medicine.

    Other details

    • Can be taken with or without food, as advised by your doctor
    • To be taken as instructed by doctor
    • Does not cause sleepiness

    References

    Additional Information>

    One of the following licensed pharmacy from the nearest location will deliver ADRIBLASTINA-RD 50mg Injection 1s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

    Questions and Answers

    There are no questions yet. Be the first to ask a question about this product.

    Only registered users are eligible to enter questions

    Medicalstore.com.pk © All rights reserved

    Made with ❤ by Dairah

    Shopping Cart